Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

Immunocompromised individuals, including multiple sclerosis (MS) patients on certain immunotherapy treatments, are considered susceptible to complications from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and specific vaccination regimens have been recommended for suitable...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfonso-Dunn, Roberto, Lin, Jerry, Kirschner, Vanessa, Lei, Joyce, Feuer, Grant, Malin, Michaela, Liu, Jiayuan, Roche, Morgan, Sadiq, Saud A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388928/
https://www.ncbi.nlm.nih.gov/pubmed/35990701
http://dx.doi.org/10.3389/fimmu.2022.926318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388928/
https://www.ncbi.nlm.nih.gov/pubmed/35990701
http://dx.doi.org/10.3389/fimmu.2022.926318

Ejemplares similares